making muscle wasting history

2-'O-methyl antisense oligos (PS) targeting exon 51.

• Last Edited: 15 Sep 2010
• Permanent link

BACKGROUND:Duchenne’s muscular dystrophy is associated with severe, progressive muscle weakness and typically leads to death between the ages of 20 and 35 years. By inducing specific exon sk...

Tags: myofibers, biopsy, exon skipping, exon 51, prosensa, GSK, clinical trials.

GSK2402968 Clinical Development Programme Update

• Last Edited: 15 Apr 2011
• Permanent link

Forty-Eight Week Follow-Up Data from a Phase I/IIa Extension Study of PRO051/GSK2402968 in Subjects with Duchenne Muscular DystrophyThe following Phase I/IIa extension study results were presented...

Tags: Duchenne, DMD, GSK, Duchenne Muscular Dystrophy.